Condition
Advanced Tumors clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Advanced Tumors clinical trials that are recruiting, at sites in 3 countries (most in China (5), Australia (1), Israel (1)). By phase: Phase 1 (4), Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Advanced Tumors clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| GW01-200 tablets in people with advanced cancers | Phase 1 | Beijing, Beijing Municipality and 2 other locations | Recruiting | Jun 5, 2026 |
| SIBP-A10 injection for adults with advanced malignant tumors | Phase 1 | Dalian, Liaoning | Recruiting | Oct 3, 2025 |
| AL58805 treatment for people with advanced solid tumors. | Phase 1 | Changsha, Hunan | Recruiting | Sep 17, 2025 |
| Testing MDX2004 at increasing doses in adults with advanced tumors | Phase 1/2 | Liverpool, New South Wales and 5 other locations | Recruiting | Aug 7, 2025 |
| Personalized neoantigen vaccine combined with radiotherapy for advanced tumors | Phase 2 | Shenzhen, Guangdong and 1 other locations | Recruiting | Mar 15, 2024 |
| Evaluating CS23546 for patients with advanced tumors | Phase 1 | Guangzhou | Recruiting | Feb 7, 2024 |
All recruiting trials (6)
-
GW01-200 tablets in people with advanced cancers
This early-phase study tests GW01-200 tablets in adults with advanced solid tumors or blood cancers to see if they are safe and how they behave in the body.
-
SIBP-A10 injection for adults with advanced malignant tumors
This trial will test whether SIBP-A10 injections are safe and tolerable and to identify the best dose for adults with advanced metastatic tumors.
-
AL58805 treatment for people with advanced solid tumors.
This Phase I dose-escalation trial will test different oral doses of AL58805 in people with advanced solid tumors who have exhausted standard treatment options.
-
Testing MDX2004 at increasing doses in adults with advanced tumors
This will test whether different doses of the experimental drug MDX2004 are safe and can shrink tumors in adults with advanced or metastatic cancer.
-
Personalized neoantigen vaccine combined with radiotherapy for advanced tumors
This study is testing a personalized vaccine made from a patient's own tumor cells combined with radiotherapy to see if it can help people with advanced tumors that haven't responded to standard treatments.
-
Evaluating CS23546 for patients with advanced tumors
This study is testing a new treatment called CS23546 to see if it's safe and how well it works for people with advanced tumors.
Quick answers
How many Advanced Tumors clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (5 trials), Australia (1 trial), Israel (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.